Dan Passeri | CEO |
Matteo Levisetti | Chief Medical Officer |
Ken Pienta | Clinical Advisory |
Anish Suri | President and Chief Scientific Officer |
Kerri Millar | CFO |
Sara Pai | Surgical Oncologist and Director, Translational Head and Neck Cancer Research, Mass General Hospital |
Ted Tenthoff | Piper Sandler |
Ren Benjamin | JMP Securities |
Mark Breidenbach | Oppenheimer |
Stephen Willey | Stifel |
Greetings, and welcome to the Cue Biopharma Fourth Quarter and Full Year 2022 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mr. Dan Passeri, Chief Executive Officer. Please go ahead.